| ZAORALOVÁ, Romana, Petr KUGLÍK, Hana FILKOVÁ, Henrieta GREŠLIKOVÁ, Pavel NĚMEC, Alexandra OLTOVÁ, Luděk POUR, Zdeněk ADAM, Andrea KŘIVANOVÁ, Marta KREJČÍ and Roman HÁJEK. Clinical implications of chromosomal aberrations (13q14 and 17p13 deletion, translocation t(4;14) and 1q21 amplification) in patients with relapsed multiple myeloma treated by thalidomide or bortezomib (Velcade). In From cell sorting to plasma cell identification and chromosomal aberrations in multiple myeloma – Application manual. Brno: vydavatelství Masarykovy Univerzity, 2007, p. 12-13. ISBN 978-80-210-4417-3. |
Other formats:
BibTeX
LaTeX
RIS
@inproceedings{726821,
author = {Zaoralová, Romana and Kuglík, Petr and Filková, Hana and Grešliková, Henrieta and Němec, Pavel and Oltová, Alexandra and Pour, Luděk and Adam, Zdeněk and Křivanová, Andrea and Krejčí, Marta and Hájek, Roman},
address = {Brno},
booktitle = {From cell sorting to plasma cell identification and chromosomal aberrations in multiple myeloma – Application manual},
keywords = {Multiple myeloma; CKS1B amplification; RB deletion; p53 deletion; t(4;14); cIg FISH},
language = {eng},
location = {Brno},
isbn = {978-80-210-4417-3},
pages = {12-13},
publisher = {vydavatelství Masarykovy Univerzity},
title = {Clinical implications of chromosomal aberrations (13q14 and 17p13 deletion, translocation t(4;14) and 1q21 amplification) in patients with relapsed multiple myeloma treated by thalidomide or bortezomib (Velcade)},
year = {2007}
}
TY - JOUR
ID - 726821
AU - Zaoralová, Romana - Kuglík, Petr - Filková, Hana - Grešliková, Henrieta - Němec, Pavel - Oltová, Alexandra - Pour, Luděk - Adam, Zdeněk - Křivanová, Andrea - Krejčí, Marta - Hájek, Roman
PY - 2007
TI - Clinical implications of chromosomal aberrations (13q14 and 17p13 deletion, translocation t(4;14) and 1q21 amplification) in patients with relapsed multiple myeloma treated by thalidomide or bortezomib (Velcade)
PB - vydavatelství Masarykovy Univerzity
CY - Brno
SN - 9788021044173
KW - Multiple myeloma
KW - CKS1B amplification
KW - RB deletion
KW - p53 deletion
KW - t(4;14)
KW - cIg FISH
N2 - The aim of the work was: 1) To study the incidence of the chromosomal aberrations known as adverse prognostic factors in MM - deletion of 13q14 (RB1), deletion of 17p13 (p53), amplification of 1q21 (CKS1B) and translocation t(4;14) in a group of 40 patients with relapsed MM. 2) To compare the prognostic and predictive significance of these unfavorable chromosomal aberrations in patients with relapsed MM treated with thalidomide or bortezomib (Velcade) based regimens.
ER -
ZAORALOVÁ, Romana, Petr KUGLÍK, Hana FILKOVÁ, Henrieta GREŠLIKOVÁ, Pavel NĚMEC, Alexandra OLTOVÁ, Luděk POUR, Zdeněk ADAM, Andrea KŘIVANOVÁ, Marta KREJČÍ and Roman HÁJEK. Clinical implications of chromosomal aberrations (13q14 and 17p13 deletion, translocation t(4;14) and 1q21 amplification) in patients with relapsed multiple myeloma treated by thalidomide or bortezomib (Velcade). In \textit{From cell sorting to plasma cell identification and chromosomal aberrations in multiple myeloma – Application manual}. Brno: vydavatelství Masarykovy Univerzity, 2007, p.~12-13. ISBN~978-80-210-4417-3.
|
